This podcast is an exploration of the journey from publication to practice of The Selecting Therapeutic Targets in Inflammatory Bowel Disease initiative, otherwise known as STRIDE II. Hear from three experts in the field of IBD as they explore the creation of treat-to-target guidelines, discuss the different consideration for monitoring in Crohn’s disease and ulcerative colitis, and reveal how to implement treat-to-target guidelines in patient care. This podcast has been sponsored by Abbvie.